Marpai, Inc. (MRAI)
| Market Cap | 6.64M -55.4% |
| Revenue (ttm) | 17.13M -34.7% |
| Net Income | -16.67M |
| EPS | -0.84 |
| Shares Out | 25.33M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Average Volume | 32,425 |
| Open | 0.2608 |
| Previous Close | 0.2620 |
| Day's Range | 0.2411 - 0.2608 |
| 52-Week Range | 0.2150 - 1.7800 |
| Beta | 4.36 |
| RSI | 44.04 |
| Earnings Date | May 21, 2026 |
About Marpai
Marpai, Inc., a technology-driven healthcare payer, focuses on providing services to the self-insured employer market in the United States and Israel. The company offers ancillary services, such as care management, case management, actuarial services, health savings account administration, and cost containment services. It also develops artificial intelligence and healthcare technology that enables the analysis of data to predict and prevent events related to diagnostic errors, hospital visits, and administrative issues. The company was incorpo... [Read more]
Financial Performance
In 2025, Marpai's revenue was $18.10 million, a decrease of -35.76% compared to the previous year's $28.17 million. Losses were -$16.56 million, -25.03% less than in 2024.
Financial StatementsNews
MARPAI REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS
Strategic Investments in Operations and Technology Fuel Platform for Accelerated Growth and Aim of Second-Half 2026 Profitability TAMPA, Fla., May 15, 2026 /PRNewswire/ -- Marpai, Inc. ("Marpai" or th...
Marpai Quarterly report: Q1 2026
Marpai has published its Q1 2026 quarterly earnings report on May 15, 2026.
Marpai, Inc. Announces Significant New Business Wins across TPA and MarpaiRx; Solidifies Forecast for Profitability
TAMPA, Fla., May 11, 2026 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (OTCQX: MRAI), a leader in innovative healthcare technology, Third-Party Administration ("TPA"), and Pharmacy Benefit...
Marpai, Inc. Secures Major Strategic Marketing Collaboration to Continue Acceleration of MarpaiRx Growth Nationwide
TAMPA, Fla., April 1, 2026 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (OTCQX: MRAI), a leader in innovative healthcare technology, Third-Party Administration (TPA), and Pharmacy Benefit ...
Marpai Secures Access to Network Creating Major Growth Catalyst for MarpaiRx Representing Up to 1.5 million Covered Lives
Marketing Agreement Establishes Powerful National Distribution Channel and Expands Marpai's Revenue Growth Opportunity TAMPA, Fla., March 9, 2026 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company...
Marpai Annual report: Q4 2025
Marpai has published its Q4 2025 annual report on February 25, 2026.
Marpai, Inc. Secures Major Strategic Wins for MarpaiRx, Adding Over 19,000 Lives and Accelerating High-Growth Platform Expansion
New Client Momentum Highlights Rapid Adoption of Marpai's Disruptive, Scalable Healthcare Platform Positioned to Drive Exponential Revenue Growth and Long-Term Shareholder Value TAMPA, Fla., Feb. 23, ...
MARPAI, INC. HIRES PHARMACY EXECUTIVE MIMI DAVIS AS PRESIDENT OF MARPAIRX TO DRIVE STRATEGIC GROWTH
TAMPA, Fla., Jan. 27, 2026 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (OTCQX: MRAI), a leader in innovative healthcare technology, Pharmacy Benefit Management (PBM) and Third-Party Admin...
MARPAI ANNOUNCES 2026 MOMENTUM AND KEY PARTNERSHIP EXPANSION
Renews Aetna Signature Administrator Network Agreement and Enhances Cost Containment with Faircost Optimizer TAMPA, Fla. , Dec. 1, 2025 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (OTCQX:...
Marpai Earnings Call Transcript: Q3 2025
Q3 2025 saw a 42% revenue decline but improved operating efficiency and reduced losses. New client wins, a $3.9M capital raise, and technology upgrades position the company for growth in a rapidly expanding TPA market.
Marpai Quarterly report: Q3 2025
Marpai has published its Q3 2025 quarterly earnings report on November 13, 2025.
Marpai Earnings release: Q3 2025
Marpai released its Q3 2025 earnings on November 13, 2025, summarizing the period's financial results.
MARPAI REPORTS THIRD QUARTER 2025 FINANCIAL RESULTS
Continued Turnaround Driven by Cost Discipline and Operational Efficiency; Positioned for Strong 2026 Growth TAMPA, Fla. , Nov. 12, 2025 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (OTCQX...
MARPAI TO HOST WEBCAST ON NOVEMBER 13, 2025 TO DISCUSS THIRD QUARTER 2025 FINANCIAL RESULTS
TAMPA, Fla. , Nov. 6, 2025 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (OTCQX: MRAI), a leader in innovative healthcare technology and Third-Party Administration (TPA) services.
MARPAI RECOGNIZED AS 2025 TOP THIRD PARTY ADMINISTRATOR
Recognition Highlights Company's Stellar Reputation and Technology-Driven Approach to Smarter Healthcare and Real Savings TAMPA, Fla. , Oct. 14, 2025 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Com...
MARPAI, INC. RECEIVES ADDITIONAL $200,000 INVESTMENT FROM DAMIEN LAMENDOLA'S HILLCOUR INVESTMENT FUND
A Total of $1.7 Million Raised in Q3 2025 TAMPA, Fla. , Oct. 6, 2025 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (OTCQX: MRAI), an independent national Third-Party Administration ("TPA") ...
Marpai Earnings Call Transcript: Q2 2025
Q2 2025 saw a 35% revenue decline but significant improvements in operating expenses and net loss, reflecting strategic exits from unprofitable contracts. The relaunch of MarpaiRx and ongoing cost reductions position the company for profitability in Q1 2026.
Marpai Quarterly report: Q2 2025
Marpai has published its Q2 2025 quarterly earnings report on August 14, 2025.
Marpai Earnings release: Q2 2025
Marpai released its Q2 2025 earnings on August 14, 2025, summarizing the period's financial results.
MARPAI REPORTS SECOND QUARTER 2025 FINANCIAL RESULTS
Marpai Slashes Losses by Two-Thirds in Q2 2025, Paving the Way to Profitability. Operating Expenses Cut 70% as Turnaround Gains Traction TAMPA, Fla.
MARPAI TO HOST WEBCAST ON AUGUST 14, 2025 TO DISCUSS SECOND QUARTER 2025 FINANCIAL RESULTS
TAMPA, Fla. , Aug. 7, 2025 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (OTCQX: MRAI), a leader in innovative healthcare technology and Third-Party Administration (TPA) services.
MARPAIRX REVOLUTIONIZES PHARMACY BENEFITS WITH UNPRECEDENTED TRANSPARENCY AND SAVINGS
MarpaiRx Delivers a Win-Win for Health Plans and Members TAMPA, Fla. , July 24, 2025 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (OTCQX: MRAI), an independent national Third-Party Adminis...
Marpai Proxy statement: Proxy Filing
Marpai filed a proxy statement on July 3, 2025, providing details for shareholder voting and corporate governance matters.
Marpai Proxy statement: Proxy Filing
Marpai filed a proxy statement on June 24, 2025, providing details for shareholder voting and corporate governance matters.
Marpai Earnings Call Transcript: Q1 2025
Q1 2025 saw a 27% revenue decline but significant improvements in operating loss and net loss, driven by cost reductions and a focus on higher-margin clients. Leadership changes and a strong pipeline support expectations for profitability and cash flow positivity by year-end.